Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fioredda, 2012, Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica), Am. J. Hematol., 87, 238, 10.1002/ajh.22242
Marsh, 2009, British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia, Br. J. Haematol., 147, 43, 10.1111/j.1365-2141.2009.07842.x
Montané, 2008, Catalan Group for Study of Agranulocytosis and Aplastic Anemia. Epidemiology of aplastic anemia: a prospective multicenter study, Haematologica, 93, 518, 10.3324/haematol.12020
Young, 2008, The epidemiology of acquired aplastic anemia, Haematologica, 93, 489, 10.3324/haematol.12855
Young, 2006, Current concepts in the patho-physiology and treatment of aplastic anemia, Blood, 108, 2509, 10.1182/blood-2006-03-010777
Dufour, 2009, Marrow Failure Study Group of the AIEOP. Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia, Haematologica, 94, 1743, 10.3324/haematol.2009.007815
Dufour, 2005, Genetic polymorphisms of CYP3A4, GSTT1, GSTM1, GSTP1 and NQO1 and the risk of acquired idiopathic aplastic anemia in Caucasian patients, Haematologica, 90, 1027
Camitta, 1976, Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality, Blood, 1, 63, 10.1182/blood.V48.1.63.63
Bacigalupo, 1988, Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party, Br. J. Haematol., 2, 177, 10.1111/j.1365-2141.1988.tb02460.x
Shimamura, 2009, Clinical approach to marrow failure, Hematology Am. Soc. Hematol. Educ. Program, 329, 10.1182/asheducation-2009.1.329
Niemeyer, 2011, Classification of childhood AA and MDS, Hematology Am. Soc. Hematol. Educ. Program, 2011, 84, 10.1182/asheducation-2011.1.84
Dufour, 2014, Outcome of aplastic anemia in adolescence. A survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation, Haematologica, 99, 1574, 10.3324/haematol.2014.106096
Howard, 2004, Natural history of moderate aplastic anemia in children, Pediatr. Blood Cancer, 43, 545, 10.1002/pbc.20131
Passweg, 1997, Bone marrow transplantation for severe aplastic anemia: has outcome improved?, Blood, 90, 858
Korthof, 2013, Management of acquired aplastic anemia in children, Bone Marrow Transplant., 4, 191, 10.1038/bmt.2012.235
Kobayashi, 2006, Preceding immunosuppressive therapy with antithymocyte globulin and cyclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings, Br. J. Haematol., 135, 693, 10.1111/j.1365-2141.2006.06352.x
Schrezenmeier, 2007, Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia, Blood, 110, 1397, 10.1182/blood-2007-03-081596
Scheinberg, 2008, Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine, J. Pediatr., 153, 814, 10.1016/j.jpeds.2008.06.004
Führer, 2005, Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival, Blood, 106, 2102, 10.1182/blood-2005-03-0874
Scheinberg, 2011, Horse versus rabbit antithymocyte globulin in acquired aplastic anemia, N. Engl. J. Med., 365, 430, 10.1056/NEJMoa1103975
Marsh, 2012, Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party, Blood, 119, 5391, 10.1182/blood-2012-02-407684
Saracco, 2008, Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up, Br. J. Haematol., 140, 197, 10.1111/j.1365-2141.2007.06903.x
Marsh, 2011, Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia, Blood, 118, 2351, 10.1182/blood-2010-12-327536
Samarasinghe, 2012, Excellent outcome of matched unrelated donor transplantation in paediatric aplastic anaemia following failure with immunosuppressive therapy: a United Kingdom multicentre retrospective experience, Br. J. Haematol., 157, 339, 10.1111/j.1365-2141.2012.09066.x
Bhatnagar, 2014, Upfront matched and mismatched unrelated donor transplantation in paediatric idiopathic severe aplastic anaemia: a United Kingdom multicentre retrospective experience, Bone Marrow Transplant., 49
Samarasinghe, 2014, Immune suppression for childhood acquired aplastic anaemia and myelodysplastic syndrome: where next?, Haematologica, 99, 597, 10.3324/haematol.2014.105569
Kamio, 2011, Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group, Haematologica, 96, 814, 10.3324/haematol.2010.035600
Maciejewski, 2005, Aplastic anemia: management of adult patients, Hematology Am. Soc. Hematol. Educ. Program, 110, 10.1182/asheducation-2005.1.110
Rosenfeld, 2003, Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome, JAMA, 289, 1130, 10.1001/jama.289.9.1130
Scheinberg, 2009, Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia, Br. J. Haematol., 144, 206, 10.1111/j.1365-2141.2008.07450.x
Scheinberg, 2006, Retreatment with rabbit anti-thymocyte globulin and cyclosporin for patients with relapsed or refractory severe aplastic anaemia, Br. J. Haematol., 133, 622, 10.1111/j.1365-2141.2006.06098.x
Kosaka, 2008, Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia, Blood, 111, 1054, 10.1182/blood-2007-08-099168
Gupta, 2005, A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders, Br. J. Haematol., 129, 110, 10.1111/j.1365-2141.2005.05406.x
Scheinberg, 2012, Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia, Blood, 119, 345, 10.1182/blood-2011-05-352328
Olnes, 2012, Eltrombopag and improved hematopoiesis in refractory aplastic anemia, N. Engl. J. Med., 367, 11, 10.1056/NEJMoa1200931
Desmond, 2014, Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug, Blood, 123, 1818, 10.1182/blood-2013-10-534743
Leleu, 2006, Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens, Ann. Hematol., 85, 711, 10.1007/s00277-006-0152-y
Chuhjo, 2008, Danazol therapy for aplastic anemia refractory to immunosuppressive therapy, Am. J. Hematol., 83, 387, 10.1002/ajh.21118
Jaime-Pérez, 2011, Danazol as first-line therapy for aplastic anemia, Ann. Hematol., 90, 523, 10.1007/s00277-011-1163-x
Brodsky, 2010, High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up, Blood, 115, 2136, 10.1182/blood-2009-06-225375
Scheinberg, 2014, “Moderate” dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution, Blood, 124, 2820, 10.1182/blood-2014-05-573642
Sloand, 2010, Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab, Haematologica, 95, 382, 10.3324/haematol.2009.013557
Scheinberg, 2007, Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia, Blood, 109, 3219, 10.1182/blood-2006-09-045625
Vamvakas, 1998, Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions, Transfus. Med. Rev., 12, 258, 10.1016/S0887-7963(98)80002-3
Vamvakas, 2005, Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis, Transfus. Med. Rev., 19, 181, 10.1016/j.tmrv.2005.02.002
Treleaven, 2011, Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force, Br. J. Haematol., 152, 35, 10.1111/j.1365-2141.2010.08444.x
Lehrnbecher, 2012, Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation, J. Clin. Oncol., 30, 4427, 10.1200/JCO.2012.42.7161
Valdez, 2009, Infections in patients with aplastic anemia, Semin. Hematol., 46, 269, 10.1053/j.seminhematol.2009.03.008
Hendry, 2002, Relapse of severe aplastic anaemia after influenza immunization, Br. J. Haematol., 119, 283, 10.1046/j.1365-2141.2002.379111.x